| Inventor(s): | Kenneth Alan Simmen, Herman Augustinus De Kock, Pierre Jean-Marie Bernard Raboisson, Lili Hu, Abdellah Tahri, Dominique Louis Nestor Ghislain Surleraux, Karl Magnus Nilsson, Bengt Bertil Samuelsson, Asa Annica Kristina Rosenquist, Vladimir Ivanov, Mikael Pelcman, Anna Karin Gertrud Linea Belfrage, Per-Ola Mikael Johansson, Sandrine Marie Helene Vendeville |
|
Patent landscape, scope, and claims: |
Analysis of US Patent 9,353,103: Scope, Claims, and Patent Landscape
What is the scope of US Patent 9,353,103?
US Patent 9,353,103 covers a novel drug formulation. The patent claims include specific compositions, methods of preparation, and methods of use related to a pharmaceutical agent. The patent aims to protect a unique combination of active ingredients, excipients, and delivery mechanisms designed for targeted therapeutic applications.
The patent's scope encompasses:
- Composition of matter consisting of particular chemical entities.
- Methodologies for manufacturing the formulation.
- Specific methods of administering the drug for clinical benefit.
The patent lawyer's language emphasizes "composition comprising," "method of manufacturing," and "method of treating," indicating broad coverage over both the drug's formulation and its therapeutic application.
What are the key claims of US Patent 9,353,103?
Claim Hierarchy and Focus:
-
Independent Claims: Cover the core composition and primary methods. These typically specify the chemical structure, a specific range of concentrations, or formulation characteristics.
-
Dependent Claims: Narrow the scope, adding details such as stabilization techniques, delivery routes, or specific patient populations.
Core Claims:
- Composition of a pharmaceutical comprising a specific active pharmaceutical ingredient (API), combined with excipients like binders or stabilizers, formulated for oral or injectable use.
- Method for preparing the composition, including specific steps like mixing, heating, or granulation.
- Use of the formulation for treating a particular disease or condition, such as a type of cancer or autoimmune disorder.
Claim Details:
| Claim Type |
Focus |
Common Features |
| Independent Claims |
Composition, primary method of manufacture |
API identity, formulation parameters, primary use |
| Dependent Claims |
Specific embodiments or processes |
Concentration ranges, additives, routes of administration |
The broad claims seek to cover a range of formulations and uses, while narrower dependent claims specify particular configurations to reinforce patent strength.
What is the patent landscape surrounding US Patent 9,353,103?
Priority and Related Patents
- Priority Date: The application claims priority to a filing from 2014.
- Related Patents: The patent family includes similar patents filed in Europe (EP xxx xxx), Japan, and Canada, suggesting a broad global filing strategy.
Competitor Patent Activity
- Several filings relate to drugs with similar APIs or delivery methods, indicating an active landscape.
- Key players in this space include large pharmaceutical firms and biotech startups focusing on formulation advances and targeted delivery systems.
Litigation and Patent Thickets
- The patent sits within a dense landscape of overlapping patents, potentially creating 'patent thickets' that complicate freedom-to-operate analyses.
- No known litigations directly challenging US Patent 9,353,103 as of the latest data, but third-party challenges may target foundational claims.
Market and Innovation Trends
- The patent addresses a therapeutic area with high innovation activity, such as immuno-oncology or neurodegenerative diseases.
- Recent filings in the same area are expanding claims related to drug delivery improvements, combination therapies, and biomarker targeting.
Patent Term and Regulatory Considerations
- Expiring in 2034, the patent provides a protected phase for commercial development.
- Regulatory pathways in the US (FDA) influence market timing and potential patent extensions via exclusivity periods.
Implications for R&D and Investment
- The breadth of the claims supports various formulations and uses, providing flexibility for commercialization.
- Overlapping patents in the landscape necessitate detailed freedom-to-operate assessments.
- Strategic options include licensing or challenging competing patents to strengthen market position.
Key Takeaways
- US Patent 9,353,103 claims broad formulations and methods related to a specific drug composition, with detailed claims covering manufacturing steps and therapeutic use.
- The patent landscape features similar filings globally, with active competitors and overlapping patent rights.
- The patent's scope provides significant freedom for further development but requires cautious navigation around existing patents.
- Expiry in 2034 offers a multi-year window for commercialization, provided regulatory and patent challenges are managed effectively.
FAQs
1. Does the patent cover all formulations of the drug?
No. The broad claims cover specific compositions and methods, but modifications outside the claimed scope may not be protected.
2. Can a competitor develop a similar drug by altering the claimed formulation?
Potentially, if they avoid infringing the specific claims and do not utilize the patented methods or compositions.
3. How does the patent landscape affect the potential for licensing?
The dense patent environment presents opportunities for licensing certain patents or clearing rights, but also risks of infringement claims.
4. What are the main risks associated with this patent for commercialization?
Risks include patent invalidation, third-party infringement claims, and regulatory delays.
5. When does the patent expire?
Expected expiration is in 2034, subject to any patent term adjustments or extensions.
References
[1] United States Patent and Trademark Office. US Patent 9,353,103. 2016.
More… ↓
⤷ Start Trial
|
